C
COYA THERAPEUTICS, INC. COMMON STOCK
NASDAQ: COYA (Coya Therapeutics, Inc.)
最近更新时间: 5小时之前5.08
-0.10 (-1.93%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Coya Therapeutics, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
1.8
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 1.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.83 |
|
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 7.02% |
| 机构持股比例 | 28.08% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Dme Capital Management, Lp | 30 Jun 2026 | 2,335,540 |
| Alyeska Investment Group, L.P. | 30 Jun 2026 | 800,000 |
| Cm Management, Llc | 30 Jun 2026 | 400,000 |
| Private Management Group Inc | 30 Jun 2026 | 384,217 |
| Prosight Management, Lp | 30 Jun 2026 | 170,000 |
| Jones Financial Companies Lllp | 30 Jun 2026 | 110,910 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合